Login / Signup

Cardiovascular safety of mirabegron in individuals treated for spinal cord injury- or multiple sclerosis-induced neurogenic detrusor overactivity.

Jan KrhutPeter WohlfahrtJiří PudichEliška KufováVladimír BorovičkaKarolína BílkováRadek SýkoraJan MokrišRenata CífkováRoman ZachovalPeter Zvara
Published in: International urology and nephrology (2021)
Our results suggest that mirabegron can be safely used in the treatment of patients with SCI- and MS-induced NDO.
Keyphrases
  • spinal cord injury
  • multiple sclerosis
  • high glucose
  • diabetic rats
  • spinal cord
  • mass spectrometry
  • endothelial cells
  • oxidative stress
  • ms ms
  • botulinum toxin